Brian J. Seitz

Early Stage Partners (Early Stage Partners) is a venture capital firm founded in 2001 by Jonathan Murray. The firm is headquartered in Cleveland, Ohio.

Intellirod Spine, Inc. develops a wireless implantable microelectronic lumbar spine fusion sensor. Its strain monitoring system allows spine surgeons to assess the strain on implanted spinal fusion rods and provide evidence of rod loads indicative of loosening or increased load sharing as fusion progresses. The firm’s intellirod system provides postoperative data complementing surgeon data currently collected from flexion extension x-rays and costly high radiation CT scans. The company was founded by William P. Hnat, John F. Naber, Rolando M. Puno, Michael Voor and Kevin M. Walsh in 2003 and is headquartered in Akron, OH.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Brasseler USA, Inc. engages in the manufacturing and selling of dental and surgical instruments. It offers rotary diamonds, carbides and polishers, endodontic, power handpiece systems, procedure kits, laboratory, hygiene and hand instruments, surgical instrumentation, medical power systems, saw blades, surgery burs, and accessories. The company was founded by Peter Brasseler in 1976 and is headquartered in Savannah, GA.

TEI Biosciences, Inc. develops and distributes novel biologic products for soft tissue repair, reinforcement and reconstruction applications. Its products include SurgiMend 1.0-4.0, SurgiMend-e, SurgiMend PRS, PriMatrix, PriMatrix AG, Durepair, TissueMend and Xenform. The firm’s products are used in general surgery, plastic and reconstructive surgery, trauma, wound care and burns, neurosurgery, orthopedics and urogynecology. The company was founded in 1993 and is headquartered in Waltham, MA.

Covidien Holding, Inc. manufactures and supplies healthcare products for use in clinical and home settings. It offers medical devices, pharmaceuticals and medical supplies to hospitals, long-term care and alternate care facilities, doctors’ offices and in the home. The company is headquartered in Minneapolis, MN.

Mercy Medical Center (Iowa) operates as a not-for-profit Catholic health care provider. It offers cancer treatment, alcohol substance abuse treatment, endoscopy, general surgery, and heart center and services. The company was founded in 1893 and is headquartered in Des Moines, IA.

The Cleveland Clinic Foundation operates as a non-profit academic, research, and medical center. It offers clinic and hospital care with research and education services. The company was founded by Charles Posternack, George W. Crile, Frank E. Bunts, William E. Lower and John Phillips on February,5 1921 and is headquartered in Cleveland, OH.

The Ureteral Stent Co. operates as health care firm. The company is headquartered in Cleveland, OH.

HistoSonics, Inc. develops medical devices. The company was founded by Christine Gibbons, Jim Bertolina, Zhen Xu, William Robert, Hall Timothy, J. Brian Fowlkes, Thomas W. Davison, and Charles Cain in November 2009 and is headquartered in Ann Arbor, MI.

Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH.

Ischemia Care LLC engages in the provision of diagnostic development, laboratory testing, precision medicine, and bioinformatics. The company was founded by Jeffrey June in 2009 and is headquartered in Middletown, OH.

CardioX, Inc. develops technology to detect heart defects. It commercializes a non-invasive method for detecting the presence of a right-to-left cardiac shunt to enable closure before the occurrence of a debilitating or life threatening stroke. The company was founded by Philip E. Eggers in June 1996 and is headquartered in Columbus, OH.